Entity Common Stock, Shares Outstanding of Compass Therapeutics, Inc. from 14 Aug 2018 to 30 Oct 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Compass Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 14 Aug 2018 to 30 Oct 2025.
  • Compass Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 30 Oct 2025 was 177,862,102, a 29% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Compass Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 177,862,102 +40,272,931 +29% 30 Oct 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 138,282,498 +693,327 +0.5% 04 Aug 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 138,282,498 +693,327 +0.5% 28 Apr 2025 10-Q 08 May 2025 2025 Q1
Q3 2024 137,589,171 +10,102,845 +7.9% 08 Nov 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 137,589,171 +10,129,825 +7.9% 08 Aug 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 137,589,171 +11,081,698 +8.8% 15 Mar 2024 10-K 21 Mar 2024 2023 FY
Q3 2023 127,486,326 +1,294,853 +1% 03 Nov 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 127,459,346 +26,174,733 +26% 28 Jul 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 126,507,473 +25,204,879 +25% 10 Mar 2023 10-K 15 Mar 2023 2022 FY
Q3 2022 126,191,473 +28,159,908 +29% 07 Nov 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 101,284,613 +39,590,048 +64% 25 Jul 2022 10-Q 01 Aug 2022 2022 Q2
Q1 2022 101,302,594 +49,989,140 +97% 28 Feb 2022 10-K 18 Mar 2022 2021 FY
Q3 2021 98,031,565 +45,908,191 +88% 05 Nov 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 61,694,565 +56,694,565 +1134% 10 Aug 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 51,313,454 23 Apr 2021 10-Q 30 Apr 2021 2021 Q1
Q3 2020 52,123,374 +47,123,374 +942% 02 Nov 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 5,000,000 0 0% 08 Jun 2020 10-K 08 Jun 2020 2020 FY
Q4 2019 5,000,000 0 0% 13 Feb 2020 10-Q 14 Feb 2020 2020 Q3
Q3 2019 5,000,000 0 0% 12 Nov 2019 10-Q 13 Nov 2019 2020 Q2
Q2 2019 5,000,000 0 0% 27 Jun 2019 10-K 01 Jul 2019 2019 FY
Q4 2018 5,000,000 13 Feb 2019 10-Q 14 Feb 2019 2019 Q3
Q3 2018 5,000,000 14 Nov 2018 10-Q 14 Nov 2018 2019 Q2
Q2 2018 5,000,000 14 Aug 2018 10-Q 14 Aug 2018 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.